100 Years of Insulin Sanofi Australia

CEO of Diabetes Australia, Greg Johnson, reflects on 100 years of insulin, the enormous strides made in treatment and care, and highlights major achievements and ongoing challenges for the diabetes community.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about diabetes, diabetes management and treatments to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Australia.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101377. Date of preparation: July 2021.
References
International Diabetes Federation. IDF Diabetes Atlas, 8th ed. 2017. Available at: https://diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf. National Diabetes Services Scheme. Type 1 Diabetes. Updated 31 March 2021. Available at: https://www.ndss.com.au/wp-content/uploads/ndss-data-snapshot-202103-type1-diabetes.pdf National Diabetes Services Scheme. Type 2 Diabetes. Updated 31 March 2021. Available at: https://www.ndss.com.au/wp-content/uploads/ndss-data-snapshot-202103-type2-diabetes.pdf RACGP 2020, Management of type 2 diabetes: A handbook for general practice. Available at: https://www.racgp.org.au/getattachment/41fee8dc-7f97-4f87-9d90-b7af337af778/Management-of-type-2-diabetes-A-handbook-for-general-practice.aspx ‘Diabetes in Australia’. Diabetes Australia website. Available at: https://www.diabetesaustralia.com.au/about-diabetes/diabetes-in-australia/ Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines Med J Aust 2020; 213 (1), July 2020. Available at: https://www.mja.com.au/journal/2020/213/1/screening-assessment-and-management-type-2-diabetes-mellitus-children-and

Annette Burke, shares her rollercoaster journey living with type 2 diabetes and how the condition has impacted so many members of her family. Above all, Annette describes the measures she now takes to maintain blood sugar levels and reduce the risks of complications from diabetes.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about diabetes, diabetes management and treatments to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Australia. Honoraria were provided to Annette Burke.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101380. Date of preparation July 2021.

Leading endocrinologist, Dr Ted Wu, discusses the impact of insulin on the treatment of type 1 and type 2 diabetes. He delves into new treatment considerations and shares a personal insight into what drives him to help improve the health and wellbeing of people impacted by diabetes.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about diabetes, diabetes management and treatments to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Australia. Honoraria were provided to Dr Ted Wu.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101378. Date of preparation: July 2021.
 
REFERENCES
‘Diabetes in Australia’. Diabetes Australia website. Available at: https://www.diabetesaustralia.com.au/about-diabetes/diabetes-in-australia/ RACGP 2020, Management of type 2 diabetes: A handbook for general practice. Available at: https://www.racgp.org.au/getattachment/41fee8dc-7f97-4f87-9d90-b7af337af778/Management-of-type-2-diabetes-A-handbook-for-general-practice.aspx  

Episode 3: Credentialled Diabetes Educator, Michelle Robins, explains the changing landscape of diabetes care in Australia. She describes the many benefits of a multidisciplinary ‘team’ approach that involves more than a doctor and patient, but also pharmacists and range of allied health and medical specialists.
 
Mandatories
 
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about diabetes, diabetes management and treatments to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Australia. Honoraria were provided to Michelle Robins.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101379 Date of Preparation July 2021.
References:
National Diabetes Services Scheme. Type 2 Diabetes. Updated 31 March 2021. Available at:https://www.ndss.com.au/wp-content/uploads/ndss-data-snapshot-202103-type2-diabetes.pdf Diabetes Australia. Diabetes in Australia. 2021.